Rongxu Du, MD

Beijing Cancer Hospital
Beijing, Beijing

Disclosures:

• Employment: none
• Compensation: :Role Topic Description-End Date:
• Ownership: none
• Leadership: none

Presentation(s):

• 168 - Neoadjuvant Toripalimab plus Concurrent Chemoradiotherapy in the Locally Advanced Adenocarcinoma of Esophagogastric Junction: A Phase II Trial

  Monday, September 30, 2024
  8:30 AM – 8:40 AM ET